Ex Parte WEST - Page 3


                 Appeal No.  2000-1909                                                        Page 3                    
                 Application No.  08/790,528                                                                            

                        discloses the H-2 antagonists can be incorporated into a chewing                                
                        gum matrix and are released from said matrix.  The antacid and                                  
                        anti-flatulent are ingredients well known and often used in the                                 
                        treatment of acid reflux or GERD, as set forth previously.  H-2                                 
                        antagonists are also well known for use in the treatment of acid                                
                        reflux or GERD.  The court has determined that the combination of                               
                        two or more ingredients known in the art for the same uses is                                   
                        obvious, and unpatentable.  (In re Kerkhoven 205 USPQ 1069                                      
                        (CCPA 1980)) which states: “It is prima facie obvious to combine                                
                        two compositions each of which is taught by prior art to be useful                              
                        for same purpose in order to form [a] [sic] third composition that is                           
                        to be used for very same purpose; idea of combining them flows                                  
                        logically from their having been individually taught in prior art . . .”)                       
                        It would have been obvious to one of ordinary skill in the art at the                           
                        time the invention was made to have combined the acid production                                
                        inhibitor of Singer with the antacids and antiflatulents of                                     
                        composition marketed as Tempo, as it would lead to a longer term                                
                        inhibition of acid production, in combination with the quick acid                               
                        relief provided by the antacids and the anti-flatulent.                                         
                 Examiner’s Answer, pages 4-5.                                                                          
                        Appellant argues that there is no motivation to combine Singer with the                         
                 composition marketed as Tempo.  Appellant asserts that while Singer teaches                            
                 the use of H-2 antagonists in a chewing gum matrix for the treatment of gingivitis,                    
                 Singer teaches the use of the chewing gum matrix as a topical carrier that is                          
                 expectorated rather than be swallowed.  Thus, appellant argues there is no                             
                 motivation to combine a product that is chewed and not swallowed, i.e., the                            
                 chewing gum of Singer, with a product that is to be swallowed, i.e.. the Tempo                         
                 composition.  See Appeal Brief, pages 4-6.                                                             
                        The burden is on the examiner to set forth a prima facie case of                                
                 obviousness. See In re Alton, 76 F.3d 1168, 1175, 37 USPQ2d 1578, 1581                                 
                 (Fed. Cir. 1996).  With respect to an obviousness rejection based on a                                 
                 combination of references, as the court has stated, “virtually all [inventions] are                    





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007